CELZ stock
Table of Contents
Celz Stock Message Board ,stock celz celz stocktwits celz stock price celz stock forecast , celz stock forecast 2025, stock celz, celz price target
Basically, CELZ Creative Medical Technology Holdings Inc. COMPANY are Doing a best in medical field and company are treament of Urology Methods for Treatment of Premature Ovarian Failure and Ovarian Aging Using Regenerative Cells Urology Treatment of Erectile Dysfunction by Stem Cell Therapy
IPL 2022 ALL NEW TEAMS LIST WITH PLAYERS
MULTIBAGGER PENNY STOCKS FOR 2025 BELOW 2 RUPEES
MULTIBAGGER PENNY STOCKS FOR 2022
CELZ Creative Medical Technology Holdings Inc. COMPANY, Urology Methods of Treating Erectile Dysfunction Using Regenerative Cells and Therapeutic Energy Treatments Neuro/Oncology Treatment of Glioma by Amniotic Fluid Stem Cells and Exosomes Derived Thereof Neurology Generation of Autologous Immune Modulatory Cells for Treatment of Neurological Conditions Stem Cells Multipotent Amniotic Fetal Stem Cells.
Celz Stock Message Board
CELZ Creative Medical Technology Holdings Inc. COMPANY, Orthopedics Enhancement of Nucleus Pulposus Regeneration by Enhanced Perfusion of Perispinal Area by Combination Drug, Gene and Cellular Therapies Orthopedics Perispinal Perfusion by Administration of T Regulatory Cells Alone or in Combination with Angiogenic Cell Therapies.
CELZ stock forecast 2025
CELZ stock
celz stock CELZ Creative Medical Technology Holdings Inc. FUNDAMENTAL
| Current Market Price | 1.57USD$ |
| Market Capital | 99.34L$ |
| Earnings per share (EPS) | – |
| Price-Earning Ratio (PE) | — |
| Industry PE | — |
| 52WEEK HIGH | 34.50$ |
| 52WEEK LOW | 1.32$ |
| No. of Shares Subscribed | — |
CELZ Creative Medical Technology Holdings Inc. COMPANY, Orthopedics Treatment of Disc Degenerative Disease Immunotherapy Induction of Infectious Tolerance by Ex Vivo Reprogrammed Immune Cells Immunotherapy Generation of Autologous Immune Modulatory Cells for Treatment of Neurological Conditions.
CELZ stock forecast 2025
CELZ Creative Medical Technology Holdings Inc. celz stock
| TIME PERIOD | celz stock RETURN IN PAST |
| 5YEAR | -99% |
| 1YEAR | -93% |
| 6 MONTH | -87% |
| 3 MONTH | -32% |
| 1 MONTH | -10% |
| 1WEEK | -7% |
CELZ Creative Medical Technology Holdings Inc. COMPANY, Immunotherapy Treatment of Heart Failure and/or Post Infarct Pathological Remodeling by Ex Vivo Reprogrammed Immune Cells Immunotherapy Treatment of Diabetes Using Immune Cells Reprogrammed Ex Vivo by Regenerative Cells.
CELZ stock forecast 2025
Immunotherapy Treatment of Liver Failure by Ex Vivo Reprogrammed Immune Cells,Treatment of Chronic Rejection and Concurrent Induction of Transplantation Tolerance by Ex Vivo Altered Immune Cells.
Celz Stock Message Board
| Urology | Methods for Treatment of Premature Ovarian Failure and Ovarian Aging Using Regenerative Cells Celz Stock Message Board |
| Urology | Treatment of Erectile Dysfunction by Stem Cell Therapy |
| Urology | Methods of Treating Erectile Dysfunction Using Regenerative Cells and Therapeutic Energy Treatments Celz Stock Message Board |
| Neuro/Oncology | Treatment of Glioma by Amniotic Fluid Stem Cells and Exosomes Derived Thereof |
| Neurology | Generation of Autologous Immune Modulatory Cells for Treatment of Neurological Conditions |
| Stem Cells | Multipotent Amniotic Fetal Stem Cells |
| Orthopedics | Enhancement of Nucleus Pulposus Regeneration by Enhanced Perfusion of Perispinal Area by Combination Drug, Gene and Cellular Therapies Celz Stock Message Board |
| Orthopedics | Perispinal Perfusion by Administration of T Regulatory Cells Alone or in Combination with Angiogenic Cell Therapies |
| Orthopedics | Treatment of Disc Degenerative Disease |
| Immunotherapy | Induction of Infectious Tolerance by Ex Vivo Reprogrammed Immune Cells CELZ stock forecast 2025 |
| Immunotherapy | Generation of Autologous Immune Modulatory Cells for Treatment of Neurological Conditions |
| Immunotherapy | Treatment of Heart Failure and/or Post Infarct Pathological Remodeling by Ex Vivo Reprogrammed Immune CellsCELZ stock forecast 2025 |
| Immunotherapy | Treatment of Diabetes Using Immune Cells Reprogrammed Ex Vivo by Regenerative Cells |
| Immunotherapy | Treatment of Liver Failure by Ex Vivo Reprogrammed Immune CellsCELZ stock forecast 2025 |
| Immunotherapy | Treatment of Chronic Rejection and Concurrent Induction of Transplantation Tolerance by Ex Vivo Altered Immune Cells |